Implementation and Use of Patient-Reported Outcomes in Heart Failure with Stephen Greene, MD

Podcast

Hear from Stephen Greene, MD, as he takes a deeper dive into a recent study he led comparing use of NYHA class vs. KCCQ-OS to capture changes in disease state among patients with heart failure with reduced ejection fraction.

Episode Highlights

1:20 - Key Takeaways from Study

3:30 - Role of PROs in the Future

6:50 - Barriers to Incorporating PROs in Practice

8:30 - What prognostic value do PROs add

10:20 - Limitations within the analysis

12:57 - Plans for further study

In this episode, Stephen Greene, MD, of the Duke Clinical Research Institute, breaks down a recent study he led comparing the sensitivity of NYHA class versus patient-reported outcomes for capturing changes in disease state among patients with heart failure with reduced ejection fraction.

Briefly, the study used data from the CHAMP-HF registry to identify a cohort of more than 2k HFrEF patients and found PRO, as measured by the Kansas City Cardiomyopathy Questionnaire overall summary score (KCCQ-OS), was more sensitive and better at tracking meaningful changes in health status over time when compared to use of NYHA class.

For more on use of KCCQ-OS vs. NYHA class, check out our coverage of Greene's study.

Recent Videos
Review of Recent Advancements in Dermatology, with Matthew Zirwas, MD
Allison Moser, MSN, RN, FNP-BC | Credit: Allison Moser on LinkedIn
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD
Lucy Mathew, NP
Lavinia Iordache, PA
HCPLive Five at ESC 2024 | Image Credit: HCPLive
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
© 2024 MJH Life Sciences

All rights reserved.